CHEMICAL/BIOLOGICAL DEFENSE (EMD)

Abstract

The projects in this program element (PE) support the development, build, and test of products to verify that all operational and derived requirements have been met, and to support production or deployment decisions. The activities include mature system development, integration, and demonstration to support Milestone C decisions, and conducting operational test and evaluation of production representative articles. Individual projects include: - Contamination Avoidance (CA5): system development of reconnaissance, detection, identification, and warning systems that minimize chemical and biological (CB) contamination and prevent further cross-contamination during operations. - Homeland Defense (CM5): system development of common analytical laboratory system capabilities to conduct on-site analysis of any unknown sample and test potential life-threatening substances. - Collective Protection. (CO5): system development of collectively protected systems that are smaller, lighter, less costly to produce and maintain, and more logistically supportable enabling mission accomplishment in spaces safe from the effects of CB contamination. - Decontamination (DE5): system development of Contamination Mitigation (ConMit) systems utilizing solutions that will remove/eliminate and/or detoxify contaminated material without damaging combat equipment, personnel, or the environment. - Individual Protection (IP5): system development of the next generation protective ensembles (e.g., suits, boots, and gloves) and respiratory and ocular protection equipment (e.g., protective masks) which enable the Joint Force to operate in a contaminated CB environment with little or no degradation to his/her performance. - Information Systems (IS5): system development of information architectures, applications, and cybersecurity hardening for shaping the battlespace against CB threats. - Medical Biological Defense (MB5): product development of medical biological countermeasure platform technologies, medical biological countermeasures (vaccines and therapeutics), reagents, assays, and diagnostic equipment to provide an effective capability for medical defense against biological warfare agent threats facing U.S. Forces in the field. - Medical Chemical Defense (MC5): product development of medical materiel and other medical equipment items (e.g., diagnostic equipment, prophylactic, pre-treatment, and therapeutic drugs, and individual/casualty decontamination compounds) necessary to provide an effective capability for medical defense against chemical warfare agent threats facing U.S. Forces in the field. - Test and Evaluation (TE5): critical test capabilities, planning, and infrastructure improvements/modifications necessary to evaluate CB Defense systems in realistic operating environments. The projects in this PE support the engineering and manufacturing development phase of the Department of Defense (DoD) acquisition system and are therefore correctly placed in Budget Activity 5.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2022
Source ID
0604384BP_5_0400_PB_2022
Change Summary Explanation
Funding: FY20 (+$40.100 Million): Internal Reprogramming (FY20-31 IR) for the Coronavirus Aid, Relief, and Economic Security (CARES) Act. FY20 (-$7.424 Million): Transfer of funding to support Small Business Innovative Research/Small Business Technology Transfer efforts. FY21 (+$36.496 Million): Congressional Add for Joint vaccine for botulinum and plague vaccines funding restoration (+$26.996 Million), Congressional Add for decontamination technologies (+$5.000 Million), and Congressional Add for smallpox antiviral (+$4.500 Million). FY22 (+$88.811 Million): Increase focuses on the Botulinum Monoclonal Antibodies (BOT MAB) advanced development program, the Countering Emerging Threats - Rapid Acquisition and Investigation of Drugs for Repurposing (CET RAIDR) program which supports continuation of CARES Act funded efforts, and the Aerosol & Vapor Chemical Agent Detector (AVCAD) advanced development program (+$90.742 Million). Departmental inflation/travel adjustments (-$1.931 Million). Schedule: N/A Technical: N/A
Service Agency Name
Chemical and Biological Defense Program

Tags

Communities of Interest

  • Biomedical
  • Ground and Sea Platforms
  • Human Systems
  • Space

DTIC Thesaurus Topics

  • Agile Software Development
  • Biological Factors
  • Chemical Warfare Agents
  • Cognitive Systems Engineering
  • Control Systems
  • Detection
  • Detectors
  • Information Exchange
  • Information Systems
  • Medical Personnel
  • Performance Tests
  • Systems Engineering
  • Test And Evaluation
  • Unmanned Aerial Systems
  • Vaccines
  • Warfare
  • Warning Systems

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.

Technology Areas

  • Biotechnology
  • Cyber
  • Cyber - Quantum
  • Space

Related Documents